Primary Record
Dehydro Lovastatin
Note: Only for scientific research or as raw materials for production.
- In stock
- 4,730 g
- Purity
- 99.4 %
- CAS
- 109273-98-5
Compound Identifiers & Properties
- CAS
- 109273-98-5
- PubChem CID
- 71315317
- SMILES
- CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3CC=CC(=O)O3)C
- Canonical SMILES
- CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3CC=CC(=O)O3)[C@H]21
Names & Synonyms
- Dehydro Lovastatin
- Dehydromonacolin K
- Anhydrolovastatin
- Dehydrolovastatin
- Lovastatin EP Impurity C
- 109273-98-5
- |A,|A-Dehydrolovastatin
- 2BW5MV3UB3
- Dehydrolovastatin [EP]
- starbld0027803
- RefChem:1083071
- UNII-2BW5MV3UB3
- alpha,beta-dehydrolovastatin
- Lovastatin impurity C [EP]
- DTXSID40747447
- CHEMBL3946905
- SCHEMBL30429165
- DTXCID30698191
- C24H34O4
- MSK10321
- ZINC65739660
- DEHYDROLOVASTATIN [EP IMPURITY]
- .ALPHA.,.BETA.-DEHYDROLOVASTATIN
- L 642257
- Dehydrolovastatin 100 microg/mL in Acetonitrile
- LOVASTATIN IMPURITY C [EP IMPURITY]
- FT-0665620
- J1.095.558K
- [(1S,3R,7S,8S,8aR)-3,7-dimethyl-8-[2-[(2R)-6-oxo-2,3-dihydropyran-2-yl]ethyl]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate
- (1S,3R,7S,8S,8aR)-3,7-Dimethyl-8-(2-((2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl)ethyl)-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate
- (S)-(1S,3R,7S,8S,8aR)-3,7-Dimethyl-8-(2-((R)-6-oxo-3,6-dihydro-2H-pyran-2-yl)ethyl)-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2-methylbutanoate
- (1S,3R,7S,8S,8aR)-3,7-Dimethyl-8-[2-[(2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl]ethyl]-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl (2S)-2-Methylbutanoate (Dehydrolovastatin)
- (1S,3R,7S,8S,8aR)-3,7-Dimethyl-8-{2-[(2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl]ethyl}-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate
- Butanoic acid, 2-methyl-, (1S,3R,7S,8S,8aR)-8-(2-((2R)-3,6-dihydro-6-oxo-2H-pyran-2-yl)ethyl)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-1-naphthalenyl ester, (2S)-
- ((1S,3R,7S,8S,8aR)-3,7-dimethyl-8-(2-((2R)-6-oxo-2,3-dihydropyran-2-yl)ethyl)-1,2,3,7,8,8a-hexahydronaphthalen-1-yl) (2R)-2-methylbutanoate
- (1S,3R,7S,8S,8aR)-3,7-Dimethyl-8-[2-[(2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl]ethyl]-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl; Lovastatin Imp. C (EP); Dehydrolovastatin; Lovastatin Impurity C
- (1S,3R,7S,8S,8aR)-3,7-Dimethyl-8-[2-[(2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl]ethyl]-1,2,3,7,8,8ahexahydronaphthalen-1-yl (2S)-2-methylbutanoate
- (1S,3R,7S,8S,8aR)-3,7-Dimethyl-8-{2-[(2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl]ethyl}-1,2,3,7,8,8a-hexahydro-1-naphthalenyl (2S)-2-methylbutanoate
- (2S)-2-Methylbutanoic Acid (1S,3R,7S,8S,8aR)-8-[2-[(2R)-3,6-Dihydro-6-oxo-2H-pyran-2-yl]ethyl]-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-1-naphthalenyl Ester
- (2S)-2-Methylbutanoic acid (1S,3R,7S,8S,8aR)-8-[2-[(2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalene-1-yl ester
- (2S)-2-Methylbutyric acid (1S)-1,2,3,7,8,8aalpha-hexahydro-3beta,7alpha-dimethyl-8alpha-[2-[[(2R)-3,6-dihydro-6-oxo-2H-pyran]-2-yl]ethyl]naphthalene-1beta-yl ester